| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study
|
Durmuş, Elif Tutku
|
|
|
67 |
C |
p.
|
artikel
|
| 2 |
Association between gestational diabetes mellitus and bioavailability of insulin-like growth factors and role of their binding proteins
|
Anderlová, Kateřina
|
|
|
67 |
C |
p.
|
artikel
|
| 3 |
Corrigendum to “Insulin-like growth Factors I and II receptors in the breast cancer disparity” among African-American women [Growth Hormone & IGF Research 20 (2010) 245–254]
|
Singh, S. Kalla
|
|
|
67 |
C |
p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
67 |
C |
p.
|
artikel
|
| 5 |
Effects of 18 months of GH replacement on cardiovascular risk factors and quality of life in GH deficient adults; a randomized controlled trial using a fixed very low and a standard dose of GH
|
Götherström, Galina
|
|
|
67 |
C |
p.
|
artikel
|
| 6 |
Increase of serum lipoprotein (a), an adverse effect of growth hormone treatment
|
Laron, Zvi
|
|
|
67 |
C |
p.
|
artikel
|
| 7 |
Paradoxical GH increase during oral glucose load may predict overall remission in acromegalic patients
|
Düğer, Hakan
|
|
|
67 |
C |
p.
|
artikel
|
| 8 |
Pharmacokinetics and pharmacodynamics of once-weekly administration of JR-142, a long-acting albumin-fused human growth hormone: A rondemized, placebo-controlled phase 1 study
|
Owada, Yasuko
|
|
|
67 |
C |
p.
|
artikel
|
Tijdschrift beschrijving